sanotact Group GmbH, a Münster, Germany-based vitamins, minerals and supplements business combining CDMO services with branded products, is being acquired by Avista Healthcare Partners and Damier Group under a definitive agreement.

The company develops, manufactures and commercializes VMS products across major dosage forms and serves drugstore and distribution customers in 80 international markets.

Its brand portfolio includes sanotact, a German VMS label, alongside its full-service contract development and manufacturing operation.

Existing shareholder FLOTTE Beteiligungen GmbH will make a significant reinvestment and continue to support the company.

The transaction is subject to regulatory approvals and represents Avista Healthcare Partners’ ninth platform investment in consumer healthcare.

Alantra acted as exclusive M&A advisor to FLOTTE, with CMS as legal counsel.

White & Case advised Avista Healthcare Partners and Damier Group.